Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2006-08-22FDA Approved: PAROXETINE HYDROCHLORIDE — Supplemental Application (Apotex Corp)
FDA approved a supplemental application for Paroxetine hydrochloride submitted by Apotex Corp.
-
CLINICAL_TRIALS trial_result · 2006-08-18Clinical Trial Update: Magnetic Stimulation for Parkinson Disease [Phase 1]
Phase 1 clinical trial of magnetic stimulation for Parkinson's disease has completed; the study also includes depression as a condition.
-
CLINICAL_TRIALS trial_result · 2006-08-18Clinical Trial Update: The Use of Narrative in Public Health Research and Practice: Patient Experience of Wellness Acupuncture
A NCCIH-sponsored clinical trial evaluating narrative approaches in public health research and practice, focusing on patient experiences of …
-
CLINICAL_TRIALS trial_result · 2006-08-18Clinical Trial Update: Use of Complementary and Alternative Medicine Among Older Mexican Americans
This ClinicalTrials.gov entry reports that the study on complementary and alternative medicine use among older Mexican Americans sponsored b…
-
FDA approval · 2006-08-11FDA Approved: SERTRALINE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved an original application for sertraline (generic) by Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2006-08-03FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's venlafaxine hydrochloride as an original ANDA, making a generic version of venlafaxine hydrochloride available.
-
FDA approval · 2006-08-02FDA Approved: TRIMIPRAMINE MALEATE — Original Application (Elite Laboratories, Inc.)
FDA approved the original application for Trimipramine Maleate, a generic antidepressant manufactured by Elite Laboratories, Inc.
-
EMA withdrawal · 2006-07-27EMA Refused: Valdoxan (agomelatine) — Les Laboratoires Servier
The EMA refused the Valdoxan (agomelatine) application by Les Laboratoires Servier for major depressive disorder.
-
CLINICAL_TRIALS trial_result · 2006-07-27Clinical Trial Update: Antidepressant Prophylaxis for Interferon-Induced Depression: Efficacy of Paroxetine [Phase 4]
Phase 4 trial assessing whether paroxetine prophylaxis prevents interferon-induced depression in patients with major depressive disorder; st…
-
EMA approval · 2006-07-27EMA Refused: Thymanax (agomelatine) — Les Laboratoires Servier
The EMA refused approval for Thymanax (agomelatine) by Les Laboratoires Servier.
-
CLINICAL_TRIALS trial_result · 2006-07-25Clinical Trial Update: Duloxetine in the Treatment of Melancholic Depression [Phase 3]
A Phase 3 trial evaluating duloxetine for major depressive disorder with melancholic features has completed, sponsored by Eli Lilly and Comp…
-
CLINICAL_TRIALS trial_result · 2006-07-25Clinical Trial Update: Switching to Duloxetine From Other Antidepressants [Phase 4]
A Phase 4 trial evaluated outcomes of switching patients with Major Depressive Disorder from other antidepressants to duloxetine, sponsored …
-
CLINICAL_TRIALS trial_result · 2006-07-24Clinical Trial Update: The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant Depression [Phase 3]
This update notes the completion of a Phase 3 study evaluating the fixed-dose combination of olanzapine and fluoxetine for treatment-resista…
-
FDA approval · 2006-07-21FDA Approved: MIRTAZAPINE — Supplemental Application (Aurolife Pharma LLC)
FDA approved a supplemental application from Aurolife Pharma LLC to market a generic form of the antidepressant mirtazapine.
-
CLINICAL_TRIALS trial_result · 2006-07-19Clinical Trial Update: Dose Escalation, Double-Blind Treatment With Duloxetine Hydrochloride Once Daily Dosing for Evaluation of Safety in Major Depression [Phase 3]
Phase 3 clinical trial update evaluating dose escalation and safety of duloxetine hydrochloride given once daily for major depressive disord…
-
CLINICAL_TRIALS trial_result · 2006-07-19Clinical Trial Update: Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With Schizophrenia [Phase 4]
A Phase 4 trial comparing olanzapine to an active comparator in depression associated with schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2006-07-19Clinical Trial Update: Open-Label Treatment With Duloxetine Hydrochloride Once-Daily Dosing for Evaluation of Stabilization Dose in Patients With Major Depression [Phase 3]
Open-label Phase 3 trial evaluating once-daily duloxetine for stabilization dosing in adults with major depressive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2006-07-19Clinical Trial Update: Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder [Phase 3]
Phase 3 trial evaluating duloxetine versus placebo for prevention of relapse in major depressive disorder.
-
CLINICAL_TRIALS research · 2006-07-19Clinical Trial Update: Subject Information and Consent Form F1J-US-HMCB Duloxetine Once-Daily Dosing Versus Placebo in Patients With Major Depression and Pain [Phase 3]
This document updates the subject information and consent form for a Phase 3 trial comparing duloxetine once-daily dosing to placebo in adul…
-
CLINICAL_TRIALS trial_result · 2006-07-13Clinical Trial Update: Evaluation of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Mood Disorders [Phase 2]
This Phase 2 study evaluated repetitive transcranial magnetic stimulation (rTMS) for mood disorders and has completed. It included condition…
-
CLINICAL_TRIALS research · 2006-07-13Clinical Trial Update: Trial Investigating the Effect of Different Exercise Forms on Depression [NA]
This clinical trial update reports a study investigating the effect of different exercise forms on depression. Sponsor is Demostudiet; the t…
-
CLINICAL_TRIALS research · 2006-07-10Clinical Trial Update: Depression and Transcranial Direct Current Stimulation (tDCS) [Phase 1, Phase 2]
This document provides an update on a Phase 1/2 clinical trial evaluating transcranial direct current stimulation (tDCS) for major depressiv…
-
FDA approval · 2006-07-03FDA Approved: WELLBUTRIN XL — Supplemental Application (Bausch Health US LLC)
FDA approved a supplemental application for WELLBUTRIN XL (bupropion hydrochloride) from Bausch Health US LLC.
-
FDA approval · 2006-07-03FDA Approved: WELLBUTRIN SR — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for Wellbutrin SR (bupropion hydrochloride) from GlaxoSmithKline LLC.
-
FDA approval · 2006-06-29FDA Approved: TRANYLCYPROMINE SULFATE — Original Application (Strides Pharma Science Limited)
FDA approved a generic version of tranylcypromine sulfate for major depressive disorder under ANDA 040640, with Strides Pharma Science Limit…